News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
76,449 Results
Type
Article (1449)
Company Profile (2)
Press Release (74998)
Multimedia
Podcasts (1)
Webinars (1)
Section
Business (18554)
Career Advice (208)
Deals (4474)
Drug Delivery (3)
Drug Development (13573)
Employer Resources (15)
FDA (2726)
Job Trends (2393)
News (40290)
Policy (4675)
Tag
Academia (122)
Accelerated approval (6)
Allergies (17)
Alliances (4433)
ALS (4)
Alzheimer's disease (184)
Antibody-drug conjugate (ADC) (56)
Approvals (2898)
Artificial intelligence (42)
Autoimmune disease (17)
Automation (3)
Bankruptcy (48)
Best Places to Work (2387)
BIOSECURE Act (1)
Biosimilars (39)
Biotechnology (2)
Bladder cancer (68)
Brain cancer (7)
Breast cancer (138)
Cancer (1063)
Cardiovascular disease (77)
Career advice (186)
CAR-T (30)
CDC (1)
Cell therapy (81)
Cervical cancer (11)
Clinical research (12852)
Collaboration (203)
Compensation (85)
Complete response letters (3)
COVID-19 (265)
CRISPR (3)
C-suite (65)
Cystic fibrosis (38)
Data (1518)
Denatured (1)
Depression (25)
Diabetes (86)
Diagnostics (783)
Digital health (6)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (29)
Drug pricing (5)
Drug shortages (3)
Duchenne muscular dystrophy (45)
Earnings (11480)
Employer branding (1)
Employer resources (13)
Events (10583)
Executive appointments (76)
FDA (3480)
Fibrodysplasia Ossificans Progressiva (3)
Frontotemporal dementia (1)
Funding (150)
Gene editing (16)
Generative AI (1)
Gene therapy (60)
GLP-1 (109)
Government (492)
Grass and pollen (1)
Guidances (126)
Healthcare (1954)
HIV (15)
IgA nephropathy (22)
Immunology and inflammation (14)
Immuno-oncology (11)
Indications (43)
Infectious disease (302)
Inflammatory bowel disease (32)
Influenza (19)
Intellectual property (52)
Interviews (46)
IPO (2430)
Job creations (161)
Job search strategy (155)
JPM (2)
Kidney cancer (2)
Labor market (3)
Layoffs (12)
Leadership (2)
Legal (971)
Liver cancer (12)
Lung cancer (185)
Lymphoma (117)
Machine learning (4)
Management (7)
Manufacturing (74)
MASH (43)
Medical device (1441)
Medtech (1447)
Mergers & acquisitions (2291)
Metabolic disorders (182)
Multiple sclerosis (37)
NASH (6)
Neurodegenerative disease (23)
Neuropsychiatric disorders (14)
Neuroscience (365)
NextGen: Class of 2026 (448)
Non-profit (304)
Now hiring (1)
Obesity (48)
Opinion (12)
Ovarian cancer (26)
Pain (25)
Pancreatic cancer (41)
Parkinson's disease (38)
Partnered (1)
Patents (103)
Patient recruitment (84)
Peanut (5)
People (3654)
Pharmaceutical (4)
Phase 1 (3405)
Phase 2 (5157)
Phase 3 (5139)
Pipeline (1194)
Policy (7)
Postmarket research (586)
Preclinical (1020)
Press Release (12)
Prostate cancer (59)
Psychedelics (1)
Radiopharmaceuticals (36)
Rare diseases (152)
Real estate (273)
Recruiting (3)
Regulatory (4055)
Reports (4)
Research institute (125)
Resumes & cover letters (25)
Rett syndrome (10)
RNA editing (1)
RSV (15)
Schizophrenia (47)
Series A (12)
Series B (13)
Service/supplier (1)
Sickle cell disease (19)
Spinal muscular atrophy (12)
Sponsored (4)
Startups (155)
Stomach cancer (3)
Supply chain (11)
Vaccines (98)
Venture capital (1)
Weight loss (24)
Women's health (13)
Worklife (1)
Date
Last 7 days (79)
Last 30 days (331)
Last 365 days (5179)
2026 (443)
2025 (5210)
2024 (5649)
2023 (6155)
2022 (6743)
2021 (7433)
2020 (7004)
2019 (4887)
2018 (3858)
2017 (3840)
2016 (3211)
2015 (3732)
2014 (2596)
2013 (1943)
2012 (2029)
2011 (2117)
2010 (1825)
Location
Africa (89)
Alabama (35)
Arizona (19)
Arkansas (1)
Asia (4695)
Australia (696)
California (1985)
Canada (470)
China (156)
Colorado (76)
Connecticut (105)
Delaware (67)
Europe (10389)
Florida (306)
Georgia (64)
Hawaii (1)
Idaho (6)
Illinois (109)
India (10)
Indiana (59)
Japan (102)
Kansas (38)
Kentucky (7)
Louisiana (1)
Maine (4)
Maryland (207)
Massachusetts (1114)
Michigan (76)
Minnesota (40)
Missouri (12)
Nebraska (1)
Nevada (31)
New Hampshire (7)
New Jersey (799)
New Mexico (1)
New York (634)
North Carolina (230)
North Dakota (1)
Northern California (811)
Ohio (21)
Oregon (2)
Pennsylvania (352)
Rhode Island (3)
South America (159)
South Carolina (8)
Southern California (980)
Tennessee (20)
Texas (248)
United States (6749)
Utah (64)
Virginia (24)
Washington D.C. (13)
Washington State (136)
West Virginia (1)
Wisconsin (4)
76,449 Results for "andor".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Boehringer Ingelheim convenes “Detect the SOS” Collective for public health mission: increase uACR screening among adults with type 2 diabetes and/or high blood pressure to help uncover kidney damage and elevated heart risks
January 29, 2026
·
7 min read
Press Releases
HUTCHMED Announces Enrollment Completed of SAFFRON Global Phase III Trial of ORPATHYS® and TAGRISSO® Combination for Certain Lung Cancer Patients with MET Overexpression and/or Amplification After Progression on TAGRISSO®
November 4, 2025
·
11 min read
Press Releases
BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial of ML-016 in Advanced Cancers with Lung and/or Liver Involvement
October 7, 2025
·
5 min read
Press Releases
BrYet US, Inc. Receives Approval to Initiate in Australia a First-in-Human Phase 1/2 Trial Study of ML-016 in Advanced Cancers with Lung and/or Liver Involvement
October 6, 2025
·
1 min read
Press Releases
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
May 14, 2025
·
7 min read
Press Releases
Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations
January 22, 2025
·
4 min read
Press Releases
Tharimmune Announces Positive FDA Feedback on NDA Path for TH104 for Prophylaxis of Respiratory and/or CNS Depression for Ultrapotent Opioid Exposure
April 1, 2025
·
6 min read
Press Releases
Lyell Immunopharma Receives Regenerative Medicine Advanced Therapy (RMAT) Designation for LYL314 for the Treatment of Relapsed and/or Refractory Large B-Cell Lymphoma
April 15, 2025
·
8 min read
Press Releases
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
March 5, 2025
·
7 min read
Biotech Bay
Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced that it intends to offer and sell shares of its common stock and/or pre-funded warrants in an underwritten public offering.
September 27, 2023
·
4 min read
1 of 7,645
Next
